相关实验视频

Updated: Mar 6, 2026

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

清晰的蛋白质特征驱动了萨科佩尼亚的进展:一个纵向的多队列研究

Sung Hye Kong^1,2, Ok Hee Jeon³, Ji Yeon Kim³

¹Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

Journal of cachexia, sarcopenia and muscle

|March 5, 2026

概括

这项研究确定了与肉症进展相关的血蛋白签名. 这些生物标志物,包括补体激活和炎症反应,可能有助于早期检测和干预与年龄相关的肌肉损失.

科学领域:

老年学是指老年学的学科.
生物化学生化学
分子生物学分子生物学

背景情况:

肉症是肌肉质量和功能与年龄相关的显著下降,导致虚弱和健康状况不佳.
有限的纵向数据和外部验证存在于肉症进展的分子生物标志物.

研究的目的:

通过使用高通量蛋白质组分析,识别和验证与肉症进展相关的血蛋白生物标志物.
调查涉及萨科佩尼亚发育和维持的潜在分子途径.

主要方法:

应用数据独立采集 (DIA) 质谱法对来自两个独立前队列 (n=171和n=93) 的血样本.
利用有针对性的量化和免疫测试来验证关键蛋白质发现.
进行多变量回归和途径丰富分析以确定重要的关联和生物机制.

主要成果:

在发现队列中确定了102种差异表达的蛋白质;APOA1,KLKB1和LECT2在患有肉症的个体中显示出显著的变化.
在持久性sarcopenic个体中观察到B2M,S100A9和LYZ的升高.
验证了七种蛋白质签名 (LRG1,CST3,TIMP1,C2,ITIH1,AMBP,LYZ) 在两个队列中都与皮症组件一致相关.

结论:

已识别和验证的血蛋白签名和与肉症进展相关的途径.
突出了补体激活,急性炎症反应和脂质失调作为中心机制.
建议这些经过验证的生物标志物作为早期发现和干预策略的潜在目标.

关键词:

生物标志物生物标志物补充级联级联的补充.脂质新陈代谢脂质新陈代谢蛋白质组学蛋白质组学这种类型的麻症是sarcopenia.

更多相关视频

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...